Fresenius Kabi Announces 100,000 Euro Grant to Support Clinical Nutrition Research in Latin America

Friday, February 23, 2018 Diet & Nutrition News
Email Print This Page Comment bookmark
Font : A-A+

BAD HOMBURG, Germany, February 23, 2018 /PRNewswire/ --

Applications now open for first "Parenteral

Nutrition Research Grant Latin America"  

The Parenteral Nutrition Research Grant Latin America is now accepting applications.

To

view the Multimedia News Release, please click:  https://www.multivu.com/players/es-es/8261751-fresenius-kabi-financiar-nutricion/

The Parenteral Nutrition Research Grant Latin America, announced today by the international healthcare company Fresenius Kabi, will be awarded to an institution with an original project directly related to the therapeutic area of clinical nutrition.

This is the first time Fresenius Kabi has offered this EUR 100,000* grant, which will support research in parenteral nutrition (PN) in hospitalized adult patients in Latin America. This Grant was created to support research dedicated to improving the care of hospitalized adult patients in Latin America, of whom 74 percent are moderately or severely malnourished.1

The application deadline is July 15, 2018. Applications will be reviewed by experts in the field of clinical nutrition, and the winner will be announced at the FELANPE in 2018.

*Euro amount or equivalent in local currency

For more information, please visit http://www.fresenius-kabi.com, or email parenteralnutrition.research.grant@fresenius-kabi.com

References 

  1. Papapietro Vallejo K, Méndez Martínez C, Matos Adames AA et al. Current Clinical Nutrition Practices in Critically Ill Patients in Latin America: A Multinational Observational Study. Crit Care 2017; 21 (1), 227. DOI: 10.1186/s13054-017-1805-z

     (Logo: https://mma.prnewswire.com/media/645417/Fresenius_Kabi_Latin_America_Research_Grant_Logo.jpg ) Video:       https://www.multivu.com/players/es-es/8261751-fresenius-kabi-financiar-nutricion/

SOURCE Fresenius Kabi



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store